Cargando…

Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer

PURPOSE: The IDEAL-CRT phase 1/2 multicenter trial of isotoxically dose-escalated concurrent chemoradiation for stage II/III non-small cell lung cancer investigated two 30-fraction schedules of 5 and 6 weeks’ duration. We report toxicity, tumor response, progression-free survival (PFS), and overall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fenwick, John D., Landau, David B., Baker, Angela T., Bates, Andrew T., Eswar, Chinnamani, Garcia-Alonso, Angel, Harden, Susan V., Illsley, Marianne C., Laurence, Virginia, Malik, Zafar, Mayles, William Philip M., Miles, Elizabeth, Mohammed, Nazia, Spicer, James, Wells, Paula, Vivekanandan, Sindu, Mullin, Anne-Marie, Hughes, Laura, Farrelly, Laura, Ngai, Yenting, Counsell, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier, Inc 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049901/ https://www.ncbi.nlm.nih.gov/pubmed/31809876 http://dx.doi.org/10.1016/j.ijrobp.2019.11.397

Ejemplares similares

IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer
por: Landau, David B., et al.
Publicado: (2016)

Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer
por: Conibear, John, et al.
Publicado: (2018)

Isotoxic dose escalated radiotherapy for glioblastoma based on diffusion-weighted MRI and tumor control probability—an in-silico study
por: Pang, Yaru, et al.
Publicado: (2023)

The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer
por: Vivekanandan, S., et al.
Publicado: (2017)

Dose Escalation for Pancreas SBRT: Potential and Limitations of using Daily Online Adaptive Radiation Therapy and an Iterative Isotoxicity Automated Planning Approach
por: Rhee, Dong Joo, et al.
Publicado: (2023)

Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study
por: Haslett, Kate, et al.
Publicado: (2021)

Treating locally advanced lung cancer with a 1.5 T MR-Linac – Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy
por: Bainbridge, Hannah E., et al.
Publicado: (2017)

Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study
por: Haslett, Kate, et al.
Publicado: (2016)

CRT-D or CRT-P in CRT-indicated patients?
por: Kaya, Adnan, et al.
Publicado: (2017)

Improved effectiveness of stereotactic radiosurgery in large brain metastases by individualized isotoxic dose prescription: an in silico study
por: Zindler, Jaap D., et al.
Publicado: (2018)

CRT-D or CRT-P?: the endless debate!
por: Daubert, J Claude
Publicado: (2023)

Individual isotoxic radiation dose escalation based on V20 and advanced technologies benefits unresectable stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy: long term follow-up
por: Liu, Ming, et al.
Publicado: (2017)

Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinoma
por: Bouchart, Christelle, et al.
Publicado: (2021)

The risk of ventricular arrhythmias in a Dutch CRT population: CRT-defibrillator versus CRT-pacemaker
por: ter Horst, I. A. H., et al.
Publicado: (2016)

Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer
por: Hawranko, Robert, et al.
Publicado: (2022)

The universal CRT controller
por: Lips, R
Publicado: (1984)

Role of echocardiography in CRT
por: Tayal, Bhupendar, et al.
Publicado: (2018)

Virtual Works for CRT()
por: Waksman, Ron
Publicado: (2021)

Study protocol: a multicentre, prospective, phase II trial of isotoxic hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer
por: Liu, Yue-E, et al.
Publicado: (2020)

Prognosis of CRT-treated and CRT-untreated unselected population with LBBB in Stockholm County
por: Gatti, Paolo, et al.
Publicado: (2023)

Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases
por: Lee, Siow Ming, et al.
Publicado: (2014)

Follow-up of CRT-D patients downgraded to CRT-P at the time of generator exchange
por: Frey, Simon Martin, et al.
Publicado: (2023)

Correction: Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study
Publicado: (2016)

Image performance in CRT displays
por: Compton, Kenneth
Publicado: (2003)

The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients
por: Zhang, Yanqiu, et al.
Publicado: (2019)

Clinical decision tool for CRT-P vs. CRT-D implantation: Findings from PROSE-ICD
por: Nauffal, Victor, et al.
Publicado: (2017)

Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen
por: Habr-Gama, Angelita, et al.
Publicado: (2016)

A Phase I Study of Concurrent Individualized, Isotoxic Accelerated Radiotherapy and Cisplatin–Vinorelbine–Cetuximab in Patients With Stage III Non–Small-Cell Lung Cancer
por: Dingemans, Anne-Marie C., et al.
Publicado: (2014)

Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation
por: Manderlier, Martin, et al.
Publicado: (2022)

Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer
por: Turtle, Louise, et al.
Publicado: (2021)

CRT device for the analysis of Mirabelle pictures
por: Bourdinaud, M, et al.
Publicado: (1974)

Patients predict their own outcome with CRT
por: Kronborg, M.B., et al.
Publicado: (2015)

CRT 2020, COVID-19 and Beyond()
por: Waksman, Ron
Publicado: (2020)

Adaptive CRT algorithm and electrical synchrony
por: Bank, A, et al.
Publicado: (2023)

Creatine Transporter (CrT; Slc6a8) Knockout Mice as a Model of Human CrT Deficiency
por: Skelton, Matthew R., et al.
Publicado: (2011)

Visualization of the SyncAV(®) Algorithm for CRT Optimization by Non-invasive Imaging of Cardiac Electrophysiology: NICE-CRT Trial
por: Spitaler, Philipp, et al.
Publicado: (2023)

Structure and Drug Resistance of the Plasmodium falciparum Transporter PfCRT
por: Kim, Jonathan, et al.
Publicado: (2019)

Improvement in CRT: new strategies, better choices
por: van der Wall, E. E.
Publicado: (2014)

BLOCK-HF: CRT gains new ground
por: ElGuindy, Ahmed M., et al.
Publicado: (2013)

Upgrading and replacement in CRT devices: experience counts
por: de Voogt, W.G.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e3195mn7ngm2v3p54icn5p30q7